إعلان
إعلان
PRAX
Praxis Precision Medicines, Inc. Common Stock
286.58
USDبرعاية
-8.16
-2.77%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
286.57
0.00
0.00%
تقارير أرباح PRAX
النسبة الإيجابية المفاجئة
PRAX تفوق 9 من 21 آخر التقديرات.
43%
التقرير التالي
بيانات التقرير القادم
٢٦ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$51.00K
/-$3.13
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-6.85%
التغير الضمني من Q4 24 (Revenue/ EPS)
-99.32%
/+6.46%
Praxis Precision Medicines, Inc. Common Stock earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, PRAX reported earnings of -3.36 USD per share (EPS) for Q3 25, beating the estimate of -3.51 USD, resulting in a 4.30% surprise. Revenue reached --, compared to an expected 39.23 ألف, with a -100.00% difference. The market reacted with a -4.14% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analysts forecast an EPS of -3.13 USD, with revenue projected to reach 51.00 ألف USD, implying an decrease of -6.85% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Praxis Precision Medicines, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Praxis Precision Medicines, Inc. Common Stock reported EPS of -$3.36, beating estimates by 4.3%, and revenue of $0.00, -100% below expectations.
How did the market react to Praxis Precision Medicines, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.14%, changed from $171.75 before the earnings release to $164.64 the day after.
When is Praxis Precision Medicines, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٦ فبراير ٢٠٢٦.
What are the forecasts for Praxis Precision Medicines, Inc. Common Stock's next earnings report?
Based on 17
analysts, Praxis Precision Medicines, Inc. Common Stock is expected to report EPS of -$3.13 and revenue of $51.00K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان